MT 1711 P1-P5-Diadenosine 5'-pentaphosphate, [3H]- |
|
Delivered ≥ 95% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 912.3 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 591 P1-P4-Diadenosine 5'-tetraphosphate, [3H]- |
|
Delivered ≥ 95% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 836.4 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1525 P1-P3-Diadenosine triphosphate, [3H]- |
|
Delivered ≥ 96% pure with dated HPLC radiochromatogram |
|
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 5 Ci(185 GBq)/mmol | Please Inquire for Pricing |
| NextGen V-Vial - shipped on dry ice | |
| M.W. 756.4 for free acid | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |